Medicines, Controlled Drugs and Pharmacy Legislation Unit
Medicines, Controlled Drugs and Pharmacy Legislation Unit develops policy and legislation in relation to medicines, cosmetics, poisons, controlled drugs and pharmacy services.
The Unit engages at EU and international level in relation to the development and implementation of pharmaceutical policy and medicines legislation.
Medicines
Key objectives
To ensure that an appropriate legal framework, policies and relevant structures are in place to protect the health and safety of the public with regard to medicinal products, cosmetic products, poisons and medical devices; including contributing to policy development at EU and international level.
Reponsibilities:
- Responsible for the development of policy with regard to medicinal products, medical devices, clinical trials, cosmetics and poisons,
- Transposition of relevant EU legislation,
- Participation in EU Working Groups and Standing Committees and in international meetings
- Monitoring and evaluating the work of the Irish Medicines Board, the statutory agency responsible for the regulation of human and veterinary medicines, cosmetics and clinical trials in Ireland.
Agencies
Irish Medicines Board www.imb.ie
The Irish Medicines Board (IMB) protects and enhances public and animal health through the regulation of human and veterinary medical products. Among the IMB’s areas of responsibility are regulation of clinical trials, as well as monitoring and inspecting products on the market to ensure their safety and efficacy. The IMB is the Competent Authority for the implementation of EU and national legislation relating to Blood and Blood Components, Tissue and Cells, Medicinal Products, Medical Devices and Cosmetics.
Other Related Bodies
The European Medicines Agency www.ema.europa.eu
The European Medicines Agency (EMA) is the European Union body responsible for coordinating the evaluation, supervision and pharmacovigilance of medicinal products at EU level. The Agency provides the Member States and the institutions of the EU with scientific advice on any question relating to the evaluation of the quality, safety and efficacy of medicinal products for human or veterinary use referred to it in accordance with the provisions of EU legislation relating to medicinal products.
European Commission
The European Commission Directorate General for Health and Consumers (SANCO) Pharmaceuticals Unit has responsibility for medicinal product regulation:
The European Commission Directorate General for Health and Consumers (SANCO) Cosmetics and Medical Devices Unit has responsibility for cosmetics and medical devices:
Legislation
Irish Medicines Board Act 1995 (as amended)
Irish Medicines Board (miscellaneous provisions) Act 2006
Medicinal Products (link to the following legislation on a separate page)
Medicinal Products (Prescription and Control of Supply) Regulations 2003
Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005
Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2007
Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2008
Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2009
Medicinal Products (Control of Placing on the Market) Regulations 2007
Medicinal Products (Control of Placing on the Market) Regulations 2007 (Amendment) Regulations 2009
Medicinal Products (Control of Placing on the Market) Regulations 2007 (Amendment) Regulations 2010
Medicinal Products (Control of Manufacture) Regulations 2007
Medicinal Products (Control of Manufacture) Regulations 2007 (Amendment) Regulations 2009
Medicinal Products (Control of Manufacture) Regulations 2007 (Amendment) Regulations 2010
Medicinal Products (Control of Wholesale Distribution) Regulations 2007
Medicinal Products (Control of Wholesale Distribution) Regulations 2007 (Amendment) Regulations 2009
Medicinal Products (Control of Wholesale Distribution) Regulations 2007 (Amendment) Regulations 2010
Medicinal Products (Control of Advertising) Regulations 2007
European Communities (Clinical Trials on Medicinal Products for Human Use) Regulations 2004
Medicinal Devices (link to the following legislation on a separate page)
European Communities (Medical Devices) Regulations, 1994
European Communities (Active Implantable Medical Devices) Regulations, 1994
European Communities (Medical Devices) (Amendment) Regulations, 2001
European Communities (In-vitro Diagnostic Medical Devices) Regulations, 2001
European Communities (Medical Devices) (Amendment) Regulations, 2002
European Communities (Medical Devices) (Tissues of Animal Origin) Regulations, 2003
European Communities (Medical Devices) (Amendment) Regulations, 2009
European Communities (Active Implantable Medical Devices) (Amendment) Regulations, 2009
Cosmetics (link to the following legislation on a separate page)
European Communities (Cosmetic Products) Regulations 2004
European Communities (Cosmetic Products) (Amendment) Regulations 2005
European Communities (Cosmetic Products) (Amendment No. 2) Regulations 2006
European Communities (Cosmetic Products) (Amendment No. 3) Regulations 2006
European Communities (Cosmetic Products) (Amendment No. 4) Regulations 2006
European Communities (Cosmetic Products) (Amendment No. 5) Regulations 2007
European Communities (Cosmetic Products) (Amendment) Regulations 2008
European Communities (Cosmetic Products) (Amendment No. 2) Regulations 2008
European Communities (Cosmetic Products) (Amendment) Regulations 2009
European Communities (Cosmetic Products) (Amendment No. 2) Regulations 2009
European Communities (Cosmetic Products) (Amendment) Regulations 2010
European Communities (Cosmetic Products) (Amendment) (No. 2) Regulations 2010
European Communities (Cosmetic Products) (Amendment) (No. 3) Regulations 2010
Useful Links
Medicines Directive 2001/83/EC
Medical Devices Directive 2007/47/EC
Section 15 of FOI Act
Record Classes N/A
Significant Systems N/A
Personal Information Holdings N/A
Purpose N/A
Disclosees N/A
Notes: including information on admin access practice, Ebriefs etc: Standard policy and briefing documentation
Contact this Division
Contact this Unit
Staff:
Chief Pharmacist: Marita Kinsella
Assistant Principals: Mary Dowling
Pharmacist: Noreen Quinn
Tel. No. 01-6354000
Email medicines_unit@health.gov.ie
Pharmacy Legislation and Regulation Section
Key Objectives
To develop and implement policy and legislation in relation to the regulation of pharmacists and pharmacies, including the development of pharmacy education and training policy and the professional role of the pharmacist in the healthcare system.
Reponsibilities:
- To input into the development of the professional role of pharmacists, including education and in the context of the development of pharmacy services.
- Oversight of the regulation of pharmacists and pharmacies and the implementation of the Pharmacy Act 2007 as amended.
- Monitoring of the Pharmaceutical Society of Ireland, including governance and operations under the Pharmacy Act 2007.
- Chairing the Medication Safety Forum which has taken up the role of implementing the medication safety recommendations of the Report of the Commission on Patient Safety “Building a culture of patient safety’’.
- Agencies and other Relevant Bodies
- Legislation
- Useful Links
- Section 15 of FOI Act
- Contact this Office
Agencies and other Relevant Bodies
The Pharmaceutical Society of Ireland (PSI) www.thepsi.ie
The PSI was established under the Pharmacy Act 2007 as the pharmacy regulator to act in the interests of patient safety and public protection.
The main role of the PSI includes:
- registration of pharmacists and pharmacies;
- handling complaints and disciplinary matters, including fitness to practice and the imposition of sanctions;
- inspection and enforcement of pharmacies, including the taking of prosecutions;
- accreditation of educational programmes for the pharmacy profession;
- actions to improve the profession of pharmacy;
- quality assurance of standards, and the development of pharmacy practice;
- provision of advice to the Government on pharmacy care, treatment and service in Ireland.
Legislation
Pharmacy Act 2007 (No. 20 of 2007) as amended by the (European Communities (Recognition of Professional Qualifications relating to the profession of pharmacist) (No. 2) Regulations 2008, S.I. No. 489 of 2008)
http://www.oireachtas.ie/documents/bills28/acts/2007/a2007.pdf
http://www.dohc.ie/legislation/statutory_instruments/pdf/si20080489.pdf?direct=1
Regulation of Retail Pharmacy Businesses Regulations 2008, S.I. No. 488 of 2008
Pharmaceutical Society of Ireland (Council) Rules 2008, S.I. No. 492 of 2008
Pharmaceutical Society of Ireland (Education and Training) Rules 2008, S.I. No. 493 of 2008
Pharmaceutical Society of Ireland (Registration) Rules 2008, S.I. No. 494 of 2008
Pharmaceutical Society of Ireland (Fees) Rules 2008 and 2010, S.I. 496 of 2008 as amended by S.I. No. 257 of 2010
http://www.irishstatutebook.ie/2008/en/si/0496.html
http://www.irishstatutebook.ie/2010/en/si/0257.html
Useful Links
Section 15 of FOI Act
Record Classes N/A
Significant Systems N/A
Personal Information Holdings N/A
Purpose N/A
Disclosees N/A
Notes: including information on admin access practice, Ebriefs etc: Standard policy and briefing documentation
Contact this Unit
Staff:
Chief Pharmacist: Marita Kinsella
Assistant Principals: Eddie Quigley
Pharmacist: Noreen Quinn
Tel. No. 01-6354000
Fax No. 01-6354369
Controlled Drugs Legislation Unit
Key Objectives
To develop and implement policy and legislation on the control of drugs and precursor substances in accordance with national policy and international conventions, and to maintain the Misuse of Drugs legislation as fit for purpose.
Reponsibilities:
- Regulation of controlled drugs and precursor substances under Misuse of Drugs legislation, and EU legislation including the control of new psychoactive substances.
- Maintaining the Misuse of Drugs legislation as fit for purpose.
- Authorising supply of methadone scripts to GPs and supply of methadone to pharmacies for palliative care.
- Processing of Import/Export Licences etc. for controlled drugs.
- Agencies and other Relevant Bodies
- Legislation
- Useful Links
- Publications
- Section 15 of FOI Act
- Contact this Office
Agencies and other Relevant Bodies
National Advisory Committee on Drugs (NACD)
United Nations Office of Drugs and Crime (UNODC)
International Narcotics Control Board (INCB)
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Legislation
Misuse of Drugs Act 1977, as amended and Regulations made thereunder -
www.irishstatutebook.ie/1977/en/act/pub/0012/index.html
Misuse of Drugs Regulations 1988
Misuse of Drugs (Amendment No. 1) Regulations 1999
Misuse of Drugs (Amendment) Regulations 2006
Misuse of Drugs (Amendment) Regulations 2007
Misuse of Drugs (Amendment) Regulations 2009
Misuse of Drugs (Amendment) (No.2) Regulations 2009
Misuse of Drugs (Amendment) Regulations 2010
Misuse of Drugs (Amendment) (No.2) Regulations 2010
Misuse of Drugs (Supervision of Prescription and Supply of Methadone) Regulations 1998
Useful Links
UN Convention on Narcotic Drugs 1961
UN Convention on Psychotropic Substances 1971
UN Convention on Precursor Substances 1988
Publications
National Drugs Strategy (Interim) 2009 – 2016
The Introduction of the Opioid Treatment Protocol 2010
Section 15 of FOI Act
Record Classes N/A
Significant Systems N/A
Personal Information Holdings N/A
Purpose N/A
Disclosees N/A
Notes: including information on admin access practice, Ebriefs etc: Standard policy and briefing documentation
Contact this Unit
Staff:
Chief Pharmacist: Marita Kinsella
Assistant Principals: Siobhan Kennan
Pharmacist: Noreen Quinn
Tel. No. 01-6354000
Fax No. 01-6354369

